Payday loans-about-us page
payday loans
50 up to
MuseXRThomas@gmail.com
Payday loans
Skip to content
Skip to main navigation
Skip to first column
Skip to second column
TraQ Program of the BC PBCO
Home
About TraQ
Contributors
Contact
Guidelines & Standards
Canadian
International
Continuing Education
Case Studies
A-Level
B-Level
O-Level
Other CE
Resources
For Nurses
Manuals
TraQ/PBCO Manuals
Other Manuals
Literature Clearinghouses
TraQ Library
Videos
Jobs
Calendar of Events
Links
News
Monthly Newsletter
Canadian
International
Industry
Disease Clearinghouses
WNV
vCJD
Chagas Disease
Emerging Diseases
Home
Sunday, 26 May 2013
Main Menu
Home
About TraQ
Contributors
About Marilyn Collins
About Ann Wilson
About Veronika Pulley
About Wendy Owens
About Lisa Merkley
About Nancy Heddle
About Kate Gagliardi
About Kathleen Eckert
About Ahmed Coovadia
About Penny Chan
About Ray Berger
About Chad Milford
About Cheryl Cooper
About Maureen Wyatt
About Dianne Powell
About Heather Mah
About Pat Letendre
About Debra Lane
About Sharon Herd
About Lee Grabner
About Gwen Clarke
About Kieran Biggins
About Laurie Beitel
About Daryl Gouthro
Contact
Style Guide (Example Only)
Terms of Use & Privacy Policies
Contributors
Contact
Guidelines & Standards
Canadian
International
Canadian Transfusion Guidelines and Standards for Best Practice
International Transfusion Guidelines and Standards for Best Practice
Continuing Education
Case Studies
A-Level
Case A8: Severe Hemolytic Transfusion Reaction Involving a Student
Case Study A8 - Testing Errors - Answer
Case Study A8 - Regulations & Standards - Answer (Question 1)
Case Study A8 - Risk Management - Answer (Question 2)
Case Study A8 - Risk Management - Answer (Question 1)
Case Study A8 - Root Cause Analysis - Answer (Question 2)
Case Study A8 - Root Cause Analysis - Answer (Question 1)
Case Study A8 - Supervision of Students - Answer (Question 2)
Case Study A8 - Supervision of Students - Answer (Question 1)
Case Study A8 - Quiz Answers
Case Study A8 Discussion Part 4 - Supervision of Students
Case Study A8 Discussion Part 2 - Test Errors
Case Study A8 Discussion Part 1 - Root Cause Analysis
Case A7: Inter-facility Transportation of RBCs
Case Study A7 - Discussion - Answer (Question 7)
Case Study A7 - Discussion - Answer (Question 6)
Case Study A7 - Discussion - Answer (Question 5)
Case Study A7 - Discussion - Answer (Question 4)
Case Study A7 - Discussion - Answer (Question 3)
Case Study A7 - Discussion - Answer (Question 2)
Case Study A7 - Discussion - Answer (Question 1)
Case Study A7 - Discussion
Case Study A7 - Quiz Answers
Case A6: Elderly Patient With a Difficult Antibody Combination
Case A6 - Answer (Panel 3- Question #2)
Case A6 - Answer (Panel 3- Question #1)
Case A6 - Answer (Panel 2- Question #2)
Case A6 - Answer (Panel 2- Question #1)
Case A6 - Answer (Panel 1- Question #2)
Case A6 - Answer (Panel 1- Question #1)
Case Study A6 - Answer (Question 4)
Case Study A6 - Answer (Question 3)
Case Study A6 - Answer (Question 2)
Case Study A6 - Answer (Question 1)
Case Study A6 - Summary
Case Study A6 - Antibody Identification - Panel #3
Case Study A6 - Antigen Phenotyping
Case Study A6 - Antibody Identification - Panel #2
Table C.T.008: Exclusion of Antibodies
Case Study A6 - Antibody Identification - Panel #1
Case Study A6 - Initial Pretransfusion Test Results
Case A5: Adverse Reaction to Intravenous Rh Immune Globulin in a Patient with ITP
Case A5 - Answer Q#4 (Eluate Panel)
Case A5 - Answer Q#3 (Eluate Panel)
Case A5 - Answer Q#2 (Eluate Panel)
Case A5 - Answer Q#1 (Eluate Panel)
Case Study A5 - Answer (Question 10)
Case Study A5 - Answer (Question 9)
Case Study A5 - Answer (Question 8)
Case Study A5 - Answer (Question 7)
Case Study A5 - Answer (Question 6)
Case Study A5 - Answer (Question 5)
Case Study A5 - Answer (Question 4)
Case Study A5 - Answer (Question 3)
Case Study A5 - Answer (Question 2)
Case Study A5 - Answer (Question 1)
Case Study A5 - Initial Pretransfusion Test Results
Case A4: Positive DAT in a Recently Transfused Nonagenarian
Case A4 - Answer (Post-transfusion antibody Identification)
Case Study A4 - Antigen Phenotypes
Case Study A4 - Patient's Phenotyping - Answer (Question 2)
Case Study A4 - Patient Phenotyping - Answer (Question 1)
Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Exclusion 2)
Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Exclusion 1)
Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Question 1)
Case Study A4 - Antibody Identification (Eluate) - Answer (Question 1)
Case Study A4 - Answer (Question 6)
Case Study A4 - Answer (Question 5)
Case Study A4 - Answer (Question 4)
Case Study A4 - Answer (Question 3)
Case Study A4 - Answer (Question 2)
Case Study A4 - Answer (Question 1)
Case Study A4 - Summary
Case Study A4 - Post-investigation Crossmatch Results
Case Study A4 - Summary of Panels, Phenotyping, and Exclusion Cells
Case Study A4 - Antibody Identification (Eluate)
Case Study A4 - Patient's Phenotyping
Case Study A4 - Direct Antiglobulin Test
Case Study A4 - Initial Antibody Identification Results
Case Study A4 - Post-Transfusion Crossmatch Results
Case A3: Multiple Antibodies in a Mother Delivering Twins
Case Study A3 - Answer (Question 1)
Case Study A3 - Twin B Panel Results - Answer (Question 1)
Case Study A3 - Twin A Panel Results - Answer (Question 1)
Case Study A3 - Summary of Panel - Answer (Question 3)
Case Study A3 - Summary of Panel - Answer (Exclusion 6)
Case Study A3 - Summary of Panel - Answer (Exclusion 5)
Case Study A3 - Summary of Panel - Answer (Exclusion 4)
Case Study A3 - Summary of Panel - Answer (Exclusion 3)
Case Study A3 - Summary of Panel - Answer (Exclusion 2)
Case Study A3 - Summary of Panel - Answer (Exclusion 1)
Case Study A3 - Summary of Panel - Answer (Question 1)
Case Study A3 - Answer (Question 4)
Case Study A3 - Answer (Question 3)
Case Study A3 - Answer (Question 2)
Case Study A3 - Answer (Question 1)
Case Study A3 - Summary
Case Study A3 - Father's Phenotyping
Case Study A3 - Twin B Phenotyping
Case Study A3 - Twin B Panel Results (Eluate)
Case Study A3 - Twin B Blood Grouping and DAT Results
Case Study A3 - Twin A Blood Grouping and DAT Results
Case Study A3 - Antigen Phenotypes
Case Study A3 - Summary of Panel, Phenotyping, and Exclusion Cells
Case Study A3 - Phenotyping
Case Study A3 - Antibody Identification
Case Study A3 - Initial Crossmatch Results
Case A2: Falling Hemoglobin in a Recently Transfused Patient
Case Study A2 - Antibody Identification (Panel 2) - Answer
Case Study A2 - Antibody Identification (Panel 1) - Answer
Case Study A2 - Answer (Exclusion 3)
Case Study A2 - Answer (Exculsion 2)
Case Study A2 - Answer (Exclusion 1)
Case Study A2 - Summary of Panels - Answer (Question 1)
Case Study A2 - Answer (Question 5)
Case Study A2 - Answer (Question 4)
Case Study A2 - Answer (Question 3b)
Case Study A2 - Answer (Question 3a)
Case Study A2 - Answer (Question 2)
Case Study A2 - Answer (Question 1)
Case Study A2 - Summary
Case Study A2 - Patient Phenotyping (Pretransfusion Phenotyping Specimen)
Case Study A2 - Summary of Panels, Selected Cells, and Self Test
Case Study A2 - Antibody Identification (Panel 2)
Case Study A2 - Antibody Identification (Panel 1)
Case Study A2 - Type and Screen and DAT Results
Case Study A2 - Initial Type and Screening Results
Case A1: Unexpected Hemolysis in a Post-Partum Mother
Case Study A1 - Answer (Question 3)
Case Study A1 - Answer (Question 2)
Case Study A1 - Answer (Question 1)
Case Study A1 - Case Summary
Case Study A1 - Patient Phenotyping (Pretransfusion Specimen)
Case Study A1 - Compatibility Testing (Prewarm LISS-IAT)
Case Study A1 - Antibody Identification (Eluate)
Case Study A1 - Antibody Screening (Eluate)
Case Study A1 - Antibody Identification (Plasma)
Case Study A1 - Compatibility Testing (PEG-IAT) and DAT
Case Study A1 - Initial Compatibility Test Results
B-Level
Mini Case B7: Case of a Disappearing Anitbody
Case Study B7 - Antibody Identification Results - Answer (Question 12)
Case Study B7 - Antibody Identification Results - Answer (Question 11)
Case Study B7 - Antibody Investigation Results - Answer (Question 10)
Case Study B7 - Answer (Question 14)
Case Study B7 - Answer (Question 13)
Case Study B7 - Antibody Investigation Results
Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 9)
Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 8)
Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 7)
Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion)
Case Study B7 - DAT Results - Answer (Question 6)
Case Study B7 - DAT Results - Answer (Question 5)
Case Study B7 - DAT Results
Case Study B7 - Crossmatch Results - Answer (Question 4)
Case Study B7 - Crossmatch Results
Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 3)
Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 2)
Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 1)
Case Study B7 - Cheat Sheet Refresher on Indirect Antiglobulin Test
Case Study B7 - ABO/Rh and Antibody Screen Results
Case B6: ABO Group Inconsistent with Records
Case Study B6 - Suggested Answers to Quiz
Case Study B6 - Case Discussion - Answer (Question 4)
Case Study B6 - Case Discussion - Answer (Question 3)
Case Study B6 - Case Discussion - Answer (Question 2)
Case Study B6 - Case Discussion - Answer (Question 1)
Case Study B6 - Case Discussion
Case Study B6 - Pretransfusion Testing Results
Case Study B6 - Initial Pretransfusion Testing Results
Case B5: Severe Delayed Hemolytic Transfusion Reaction
Case Study B5 - Suggested Answers to Quiz
Case Study B5 - Case Discussion - Answer (Question 6)
Case Study B5 - Case Discussion - Best practices to prevent DHTR
Case Study B5 - Case Discussion - Answer (Question 5)
Case Study B5 - Case Discussion - Comparison of 1o and 2o immune responses
Case Study B5 - Case Discussion - Antibody kinetics in 1o and 2o immune responses
Case Study B5 - Case Discussion - Answer (Question 4)
Case Study B5 - Case Discussion - Answer (Question 3)
Case Study B5 - Case Discussion - Why a patient with an antibody may have a false-negative antibody screen
Case Study B5 - Case Discussion - Answer (Question 2)
Case Study B5 - Case Discussion - Answer (Question 1)
Case Study B5 - Case Discussion - Risk of releasing crossmatch-compatible units that are not antigen-typed
Case Study B5 - Case Discussion - Dosage
Case Study B5 - Case Discussion
Case Study B5 - Transfusion Reaction Investigation Results
Case Study B5 - Reference Laboratory Results
Case Study B5 - Initial Pretransfusion Testing Results
Case B4: Acute Hemolysis During Surgery
Case Study B4 - Suggested Answers to Quiz
Case Study B4 - Case Discussion - Answer (Question 6)
Case Study B4 - Case Discussion - Answer (Question 5)
Case Study B4 - Case Discussion - Answer (Question 4)
Case Study B4 - Case Discussion - Answer (Question 3)
Case Study B4 - Case Discussion - Answer (Question 2)
Case Study B4 - Case Discussion - Answer (Question 1)
Case Study B4 - Case Discussion
Case B3: ABO Discrepancy Complicated by Transfusion
Case Study B3 - Answer (Question 4)
Case Study B3 - Answer (Question 3)
Case Study B3 - Answer (Question 2)
Case Study B3 - Answer (Question 1)
Case Study B3 - Resolution - Results of Mini-Panel
Case Study B3 - Resolution
Case Study B3 - Case Discussion - Answer (Question 3)
Case Study B3 - Case Discussion - Answer (Question 2)
Case Study B3 - Case Discussion - Answer (Question 1)
Case Study B3 - Case Discussion
Case Study B3 - Results
Case B2: Missing ABO Antibodies in an Octogenarian
Case Study B2 - Answer (Question 5)
Case Study B2 - Answer (Question 4)
Case Study B2 - Answer (Question 3)
Case Study B2 - Answer (Question 2)
Case Study B2 - Answer (Question 1)
Case Study B2 - Resolution
Case Study B2 - Case Discussion - Answer (Question 5)
Case Study B2 - Case Discussion - Answer (Question 4)
Case Study B2 - Case Discussion - Answer (Question 3)
Case Study B2 - Case Discussion - Answer (Question 2)
Case Study B2 - Case Discussion - Investigation Steps
Case Study B2 - Case Discussion - Answer (Question 1)
Case Study B2 - Case Discussion
Case Study B2 - Results
Case B1: Positive DAT in a Neonate
Case Study B1 - Resolution
Case Study B1 - Case Discussion - Answer (Question 2)
Case Study B1 - Case Discussion - Answer (Question 1)
Case Study B1 - Case Discussion
Case Study B1 - Results
O-Level
Case Study O6: Transfusion Reaction Coincidental with Failure to Disobey Physician Orders
Case Study O6 - Discussion Part 4 - Answer (Question 3)
Case Study O6 - Discussion Part 4 - Answer (Question 2)
Case Study O6 - Discussion Part 4 - Answer (Question 1)
Case Study O6 - Discussion Part 3 - Answer (Question 3)
Case Study O6 - Discussion Part 4 - Education for interdisciplinary healthcare teams
Case Study O6 - Discussion Part 3 - Answer (Question 2)
Case Study O6 - Discussion Part 3 - Answer (Question 1)
Case Study O6 - Discussion Part 3 - Scope of Practice Issues
Case Study O6 - Discussion Part 2 - Answer (Question 3)
Case Study O6 - Discussion Part 2 - Answer (Question 2)
Case Study O6 - Discussion Part 2 - Answer (Question 1)
Case Study O6 - Discussion Part 1 - Answer (Question 3)
Case Study O6 - Discussion Part 1 - Answer (Question 2)
Case Study O6 - Discussion Part 1 - Answer (Question 1)
Case Study O6 - Discussion Part 2 - Investigating Adverse Events
Case Study O6 - Discussion Part 1 - Administering Blood Products
Case Study O5: Adverse event following plasma transfusion
Case Study O5 - Discussion Part 5 - Answer (Question 1)
Case Study 05 - Discussion Part 5 - Reporting Adverse Events
Case Study 05 - Discussion Part 4 - Answer (Question 3)
Case Study 05 - Discussion Part 4 - Answer (Question 2)
Case Study 05 - Discussion Part 4 - Answer (Question 1)
Case Study 05 - Discussion Part 4 - Investigating Adverse Events
Case Study 05 - Discussion Part 3 - Answer (Question 4)
Case Study 05 - Discussion Part 3 - Answer (Question 3)
Case Study 05 - Discussion Part 3 - Answer (Question 2)
Case Study 05 - Discussion Part 3 - Answer (Question 1)
Case Study 05 - Discussion Part 3 - Transfusion Record (Sample)
Case Study 05 - Discussion Part 3 - Administering Blood Products
Case Study 05 - Discussion Part 2 - Answer (Question 5)
Case Study 05 - Discussion Part 2 - Answer (Question 4)
Case Study 05 - Discussion Part 2 - Answer (Question 3)
Case Study 05 - Discussion Part 2 - Answer (Question 2)
Case Study 05 - Discussion Part 2 - Answer (Question 1)
Case Study 05 - Discussion Part 2 - Compatibility Requirements for Plasma
Case Study 05 - Discussion Part 1 - Clinical Uses of FFP
Case Study O4: Death following transfusion of group-specific RBC in a dispensary-only facility
Case Study O4 - Discussion Part 5 - Answer (Question 4)
Case Study O4 - Discussion Part 5 - Answer (Question 3)
Case Study O4 - Discussion Part 5 - Answer (Question 2)
Case Study O4 - Discussion Part 5 - Answer (Question 1)
Case Study O4 - Discussion Part 5 - Training and Competency Assessment
Case Study O4 - Discussion Part 4 - Answer (Question 4)
Case Study O4 - Discussion Part 4 - Answer (Question 3)
Case Study O4 - Discussion Part 4 - Answer (Question 2)
Case Study O4 - Discussion Part 4 - Answer (Question 1)
Case Study O4 - Discussion Part 4 - Transfusion-Related Responsibilities
Case Study O4 - Discussion Part 3 - Answer (Question 5)
Case Study O4 - Discussion Part 3 - Answer (Question 4)
Case Study O4 - Discussion Part 3 - Answer (Question 3)
Case Study O4 - Discussion Part 3 - Answer (Question 2)
Case Study O4 - Discussion Part 3 - Answer (Question 1)
Case Study O4 - Discussion Part 3 - Medical Consultation
Case Study 04 - Discussion Part 2 - Answer (Question 3)
Case Study 04 - Discussion Part 2 - Answer (Question 2)
Case Study 04 - Discussion Part 2 - Answer (Question 1)
Case Study O4 - Discussion Part 2 - Issuing blood to the OR
Case Study 04 - Discussion Part 1 - Answer (Question 4)
Case Study 04 - Discussion Part 1 - Answer (Question 3)
Case Study 04 - Discussion Part 1 - Answer (Question 2)
Case Study 04 - Discussion Part 1 - Answer (Question 1)
Case Study O4 - Discussion Part 1 - Use of Historical Blood Groups
Case Study 04 - Final Quiz - Answer (Question 10)
Case Study 04 - Final Quiz - Answer (Question 9)
Case Study 04 - Final Quiz - Answer (Question 8)
Case Study 04 - Final Quiz - Answer (Question 7)
Case Study 04 - Final Quiz - Answer (Question 6)
Case Study 04 - Final Quiz - Answer (Question 5)
Case Study 04 - Final Quiz - Answer (Question 4)
Case Study 04 - Final Quiz - Answer (Question 3)
Case Study 04 - Final Quiz - Answer (Question 2)
Case Study 04 - Final Quiz - Answer (Question 1)
Case Study O3: Method Validation in the Transfusion Service (TS)
Case Study O3 - Discussion Part 5 - Validation Examples - Tools & Resources
Case Study O3 - Discussion Part 4 - Answer (Question 3)
Case Study O3 - Discussion Part 4 - Answer (Question 2)
Case Study O3 - Discussion Part 4 - Answer (Question 1)
Case Study O3 - Discussion Part 4 - Regulations and Standards
Case Study O3 - Discussion Part 3 - Answer (Question 3)
Case Study O3 - Discussion Part 3 - Answer (Question 2)
Case Study O3 - Discussion Part 3 - Answer (Question 1)
Case Study O3 - Discussion Part 3 - When and how extensively to validate a method
Case Study O3 - Discussion Part 2 - Answer (Question 3)
Case Study O3 - Discussion Part 2 - Answer (Question 2)
Case Study O3 - Discussion Part 2 - Answer (Question 1)
Case Study O3 - Discussion Part 2 - Types of Validation
Case Study O3 - Discussion Part 1 - Answer (Question 3)
Case Study O3 - Discussion Part 1 - Answer (Question 2)
Case Study O3 - Discussion Part 1 - Answer (Question 1)
Case Study O3 - Discussion Part 1 - Introduction to Terminology
Case Study O2: Communication tools for managing patients with special transfusion needs (fludarabine therapy)
Case Study O2 - Discussion Part 2b - Answer (Question 5)
Case Study O2 - Discussion Part 2b - Answer (Question 4)
Case Study O2 - Discussion Part 2b - Answer (Question 3)
Case Study O2 - Discussion Part 2b - Answer (Question 2)
Case Study O2 - Discussion Part 2b - Answer (Question 1)
Case Study O2 - Discussion Part 2b - Communication Tools
Case Study O2 - Discussion Part 2a - Communication Tools
Case Study O2 - Discussion Part 1 - Answer (Question 4)
Case Study O2 - Discussion Part 1 - Answer (Question 3)
Case Study O2 - Discussion Part 1 - Answer (Question 2)
Case Study O2 - Discussion Part 1 - Answer (Question 1)
Case Study O2 - Discussion Part 1 - Mistake-Proofing Tools
Case Study O2 - Final Quiz - Answer (Question 10)
Case Study O2 - Final Quiz - Answer (Question 9)
Case Study O2 - Final Quiz - Answer (Question 8)
Case Study O2 - Final Quiz - Answer (Question 7)
Case Study O2 - Final Quiz - Answer (Question 6)
Case Study O2 - Final Quiz - Answer (Question 5)
Case Study O2 - Final Quiz - Answer (Question 4)
Case Study O2 - Final Quiz - Answer (Question 3)
Case Study O2 - Final Quiz - Answer (Question 2)
Case Study O2 - Final Quiz - Answer (Question 1)
Case Study O1: Severe hemolysis in a patient with immune thrombocytopenic purpura who has received intravenous Rh immune globulin*
Case Study O1 - Discussion Part 4 - Answer-1
Case Study O1 - Figure 1. Initial Antibody Identification Results (Plasma)
Case Study O1 - Figure 3 - Answer (Question 1)
Case Study O1 - Figure 4 - Selected cells* (Eluate)
Case Study O1 - Figure 3 - Antibody Identification Results (Eluate)
Case Study O1 - Figure 2 - Selected cells* (Plasma)
Case Study O1 - Discussion Part 4b - Answer (Question 1)
Case Study O1 - Discussion Part 4b - Severe hemolysis
Case Study O1 - Discussion Part 4a - Answer (Question 1)
Case Study O1 - Discussion Part 4a - Passive antibodies
Case Study O1 - Discussion Part 4 - Answer (Question 1)
Case Study O1 - Discussion Part 4 - Intravenous RhIG therapy in ITP
Case Study O1 - Discussion Part 3 - Intravenous immune globulin (IVIG)
Case Study O1 - Discussion Part 2 - Answer (Question 1)
Case Study O1 - Discussion Part 2 - Immmune thrombocytopenic purpura (ITP)
Case Study O1 - Discussion Part 1 - Answer (Question 1)
Case Study O1 - Discussion Part 1 - Determining antibody specificity
Case Study O1 - Final Quiz - Answer (Question 8)
Case Study O1 - Final Quiz - Answer (Question 7)
Case Study O1 - Final Quiz - Answer (Question 6)
Case Study O1 - Final Quiz - Answer (Question 5)
Case Study O1 - Final Quiz - Answer (Question 4)
Case Study O1 - Final Quiz - Answer (Question 3)
Case Study O1 - Final Quiz - Answer (Question 2)
Case Study O1 - Final Quiz - Answer (Question 1)
Level O ("Other") Case Studies
Other CE
Forums & Mailing Lists
General Continuing Education Resources
Case Studies
Other Continuing Education
Resources
For Nurses
Resources for Nurses
Manuals
TraQ/PBCO Manuals
TMP0021 - Transfusion Reaction Investigation
TMP0020 - Transfusion Committee Review
TMP0019 - Transfer Product with Patient
TMP0018 - Sample Send Out and Report Received
TMP0017 - Redistribution Shipment
TMP0016 - Red Cell Modification
TMP0015 - Provue® Process
TMP0014 - Pretransfusion Examination
TMP0012 - Non-Red Cell Component Selection and Modification
TMP0011 - Neonatal Red Cell Transfusion
TMP0010 - Mother and Infant Examination
TMP009 - Issue and Return
TMP0008 - Exchange Transfusion
TMP0007 - Emergency Release for Red Cells
TMP0006 - Discard & Expiry
TMP0005 - Derivative Selection & Modification
TMP0004 - Crossmatch
TMP0003 - Blood Product Retrieval
TMP0002 - Blood Product Inventory Assessment, Order and Receipt
TMP0001 - Antibody Identification
Technical Operations Manual
Laboratory Quality Manual
Technical Resource Manual and Competency Companion, 2nd edition
Other Manuals
TraQ/PBCO Manuals
Other Manuals
Literature Clearinghouses
Technology to Enhance Transfusion Safety
Pretransfusion
Economics of Blood Transfusion
Transfusion-Associated Adverse Events
Transfusion Medicine in Developing Countries
TraQ Library
EU Blood Directive
Meditech Taskbatches (Equipment Maintenance)
Meditech Daily Reagent Quality Control
Implementation of the Mak Progesa label system in BC hospitals - Status Report
Drugs Causing Immune Hemolytic Anemia and/or Positive DATs*
Motivating Trainees
A Receiving Hospital’s Perspective on Redistribution of Red Cells in British Columbia, Canada
Mock-Up of Blood Component Issue-Administration Record (Form)
Hepatitis C Recipient Notification Programs
Aspects of Conflict Resolution
Meetings as Time-Wasters
Canada's Blood Scandal
Quality Systems Literature & News
Accreditation of Canadian Transfusion Services
Videos
BC PBCO Videos
Jobs
Calendar of Events
Links
For Nurses
Manuals
Literature Clearinghouses
TraQ Library
Transfusion Medicine-Related Animations & Videos
Jobs
Calendar of Events
Links
News
Monthly Newsletter
Monthly newsletter - May 2013
Monthly newsletter - April 2013
Monthly newsletter - March 2013
Monthly newsletter - February 2013
Monthly newsletter - January 2013
Monthly newsletter - December 2012
Monthly newsletter - November 2012
Monthly newsletter - October 2012
Monthly newsletter - September 2012
Monthly newsletter - August 2012
Monthly newsletter - July 2012
Monthly newsletter - May 2012
Monthly newsletter - April 2012
Monthly newsletter - March 2012
Monthly newsletter - February 2012
Monthly newsletter - January 2012
test-newsletter
Monthly newsletter - December 2011
Monthly newsletter - November 2011
Monthly newsletter - October 2011
Monthly newsletter - September 2011
Monthly newsletter - August 2011
Monthly Newsletter - July 2011
Monthly Newsletter - June 2011
Monthly Newsletter - Dec 2010
Monthly Newsletter - Jan 2011
Monthly Newsletter - March 2011
Canadian
International
Industry
New on TraQ - April 2013 (By topic)
New on TraQ - Chronological (April 2013)
New on TraQ - March 2013 (By topic)
New on TraQ - Chronological (March 2012)
New on TraQ - February 2013 (By topic)
New on TraQ - Chronological (Feb. 2012)
New on TraQ - January 2013 (By topic)
New on TraQ - Chronological (January 2013)
New on TraQ - December 2012 (By topic)
New on TraQ - Chronological (Dec. 2012)
New on TraQ - November 2012 (By topic)
New on TraQ - Chronological (November 2012)
[Copy of] New on TraQ - Chronological
New on TraQ - October 2012 (By topic)
New on TraQ - Chronological (October 2012)
New on TraQ - September 2012 (By topic)
New on TraQ - Chronological (September 2012)
New on TraQ - August 2012 (by topic)
New on TraQ - Chronological (August 2012)
New on TraQ - July 2012 (By topic)
New on TraQ - Chronological (July 2012)
New on TraQ - July 2012 (By topic)
Chronological (June 2012)
New on TraQ - June 2012 (By topic)
New on TraQ - May 2012 (By topic)
New on TraQ - Chronological (May 2012)
New on TraQ - April 2012 (By topic)
New on TraQ - Chronological (April 2012)
New on TraQ - March 2012 (By topic)
New on TraQ - Chronological (March 2012)
February 2012 (By topic)
New on TraQ - Chronological (February 2012)
New on TraQ - January 2012 (By topic)
New on TraQ - Chronological (Jan. 2012)
New on TraQ - December 2011 (By topic)
New on TraQ - Chronological (December 2011)
New on TraQ - November 2011 (By topic)
What's New - Chronological (November 2011)
New on TraQ - October 2011
New on TraQ - Chronological (Oct. 2011)
New on TraQ - September 2011 (By topic)
New on TraQ - chronological (September 2011)
New on TraQ - chronological (August 2011)
New on TraQ - August 2011 (By topic)
New on TraQ - July 2011 (By topic)
New on TraQ - Chronological (July 2011)
New on TraQ - June 2011 (By topic)
New on TraQ - Chronological (June 2011)
New on TraQ - May 2011 (By topic)
New on TraQ - Chronological (May 2011)
New on TraQ (By topic)
New on TraQ - Chronological
New on TraQ - February 2011
New on TraQ - Archive
New on TraQ - March 2011
International
Industry
Canadian
TraQ's Monthly Newsletter
Disease Clearinghouses
WNV
vCJD
Chagas Disease
Emerging Diseases
West Nile Virus
Variant Creutzfeldt-Jacob Disease
Chagas Disease
Emerging Diseases